CapsoVision (CV) EBITDA (2024 - 2026)

CapsoVision has disclosed EBITDA across 3 years of filings, most recently posting -$7.6 million for Q2 2026.

• In Q2 2026, EBITDA fell 62.98% year-over-year to -$7.6 million; the TTM figure through Jun 2026 stood at -$27.7 million (down 36.13% YoY), while the FY2025 annual figure was -$25.5 million, down 28.11% from the prior year.
• EBITDA came in at -$7.6 million for Q2 2026 at CapsoVision, down from -$7.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$4.6 million in Q4 2024 to a low of -$8.0 million in Q3 2025.
• Average EBITDA over 3 years is -$6.2 million, with a median of -$5.8 million recorded in 2024.
• Year-over-year, EBITDA gained 11.76% in 2025 and plunged 62.98% in 2026.
• Over 3 years, EBITDA stood at -$4.6 million in 2024, then slumped by 61.07% to -$7.5 million in 2025, then decreased by 1.55% to -$7.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$7.6 million in Q2 2026, -$7.5 million in Q4 2025, and -$8.0 million in Q3 2025.